Yeuan T. Lee
George Town, 11800, Malaysia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Comparative Structure-Based Analysis of Predicted BZD9L1 Binding Modes Across Human Sirtuins.
Journal: International journal of molecular sciences
Published: June 19, 2026
Design and Development of DNA Damage Chemical Inducers of Proximity (DD-CIP) for Targeted Cancer Therapy.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Cross-species analysis identifies genotype-driven vulnerabilities in lung adenocarcinoma.
Journal: bioRxiv : the preprint server for biology
Published: September 05, 2025
BZD9L1 benzimidazole analogue hampers colorectal tumor progression by impeding angiogenesis.
Journal: World journal of gastrointestinal oncology
Published: January 03, 2023
Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine.
Journal: Acta pharmaceutica Sinica. B
Published: May 31, 2022
Sex-divergent expression of cytochrome P450 and SIRTUIN 1-7 proteins in toxicity evaluation of a benzimidazole-derived epigenetic modulator in mice.
Journal: Toxicology and applied pharmacology
Published: January 08, 2022
BZD9L1 sirtuin inhibitor: Identification of key molecular targets and their biological functions in HCT 116 colorectal cancer cells.
Journal: Life sciences
Published: November 18, 2020
Cancer-Associated Fibroblasts: Epigenetic Regulation and Therapeutic Intervention in Breast Cancer.
Journal: Cancers
Published: September 04, 2020
BZD9L1 sirtuin inhibitor as a potential adjuvant for sensitization of colorectal cancer cells to 5-fluorouracil.
Journal: Therapeutic advances in medical oncology
Published: March 20, 2019
Last Updated: 09/26/2026